1. Home
  2. WORX vs MBIO Comparison

WORX vs MBIO Comparison

Compare WORX & MBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCWorx Corp.

WORX

SCWorx Corp.

HOLD

Current Price

$0.36

Market Cap

4.3M

ML Signal

HOLD

MBIO

Mustang Bio Inc.

HOLD

Current Price

$1.00

Market Cap

4.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WORX
MBIO
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3M
4.7M
IPO Year
2016
2023

Fundamental Metrics

Financial Performance
Metric
WORX
MBIO
Price
$0.36
$1.00
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
15.0M
155.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
79.79
N/A
EPS
N/A
N/A
Revenue
$2,989,599.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$0.53
52 Week High
$1.37
$7.00

Technical Indicators

Market Signals
Indicator
WORX
MBIO
Relative Strength Index (RSI) 62.57 59.24
Support Level $0.24 $0.95
Resistance Level $0.35 $1.10
Average True Range (ATR) 0.07 0.10
MACD 0.01 0.03
Stochastic Oscillator 55.78 98.82

Price Performance

Historical Comparison
WORX
MBIO

About WORX SCWorx Corp.

SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.

About MBIO Mustang Bio Inc.

Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.

Share on Social Networks: